You are on page 1of 2

REFERENCES

1. Simons et al. International consensus on (ICON) anaphylaxis. World Allergy


Organization Journal 2014. WAO Journal 2014; 7:1-9.
2. Simons et al. World Allergy Organization Guidelines for the Assessment and
Management of Anaphylaxis. WAO Journal 2011; 4:1337.
3. Sampson H. A., Munoz-Furlong A et al. Second symposium on the definition and
management of anaphylaxis: summary report: Second National Institute of Allergy
and Infectious Disease/Food Allergy and Anaphylaxis Network Symposium. J Allergy
Clin Immunol. 2006;117:391397.
4. Dinakar Chitra. Anaphylaxis in Children: Current Understanding and Key Issues in
Diagnosis and Treatment. Curr Allergy Asthma Rep 2012; 12:641649.
5. Cheng A. Emergency treatment of anaphylaxis in infants and children. Canadian
Paediatric Society, Acute Care Committee. Paediatr Child Health 2011;16(1):35-40.
6. Kemp Stephen, Lockey Richard, et al. Epinephrine: The Drug of Choice for
Anaphylaxis A Statement of the World Allergy Organization. Review Article of
WAO Journal 2008; 7: S18-S26.
7. Peavy Richard, Metcalfe Dean. Understanding the mechanisms of anaphylaxis. Curr
Opin Allergy Clin Immunol. 2008; 8(4): 310315.
8. Simons FE, Gu X, Johnston LM, Simons KJ. Can epinephrine inhalations be
substituted for epinephrine injection in children at risk for systemic anaphylaxis?
Pediatrics 2000;106(5):1040-4.
9. Sicherer Scoot, Simons F., et al. Clinical Report : Self-injectable Epinephrine for
First- Aid Management of Anaphylaxis. Guidance for the Clinician in Rendering
Pediatric Care. American Academy of Pediatrics. doi:10.1542/peds.2006-3689
10. Russell S, Monroe K, Losek JD. Anaphylaxis management in the pediatric emergency
department: opportunities for improvement. Pediatr Emerg Care. 2010;26:716. Curr
Allergy Asthma Rep (2012) 12:641649 647
11. Wolbing F, Fischer J, Koberle M, Kaesler S, Biedermann T: About the role and
underlying mechanisms of cofactors in anaphylaxis. Allergy 2013, 68:10851092.
12. Lieberman P, Kemp S, Oppenheimer J, et al. The diagnosis and management of
anaphylaxis: an updated practice parameter. J Allergy Clin Immunol. 2005;115:S483
523.

13. Mueller UR. Cardiovascular disease and anaphylaxis. Curr Opin Allergy Clin
Immunol. 2007;7:337341.
14. Lieberman P. Use of epinephrine in the treatment of anaphylaxis. Curr Opin Allergy
Clin Immunol. 2003;3:313318.
15. Lieberman P, Nicklas RA, Oppenheimer J, et al. The diagnosis and management of
anaphylaxis practicparameter: 2010 Update. J Allergy Clin Immunol. 2010;126:477
80.
16. Ran D. Goldman. Child Health Update : Acute treatment of anaphylaxis in children.
Canadian Family Physician Le Mdecin de famille canadien 2013(59).
17. Bansal PJ, Marsh R, Patel B, Tobin MC. Recognition, evaluation, and treatment of
anaphylaxis in the child care setting. Ann Allergy Asthma Immunol. 2005;94:559.
18. Simons FER, for the World Allergy Organization. Epinephrine auto-injectors: first-aid
treatment still out of reach for many at risk of anaphylaxis in the community. Ann
Allergy Asthma Immunol 2009; 102:403409.
19. Muraro A., Roberts G., et al. The management of anaphylaxis in childhood: position
paper of the European academy of allergology and clinical immunology. Allergy
2007: 62: 857871.
20. Simons F., Roberts Janet, et al. Epinephrine absorption in children with a history of
anaphylaxis. J Allergy Clin Immunol 1998;101:33-7.